D. M. Smith

405 total citations
11 papers, 290 citations indexed

About

D. M. Smith is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, D. M. Smith has authored 11 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in D. M. Smith's work include Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). D. M. Smith is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). D. M. Smith collaborates with scholars based in United States, United Kingdom and Netherlands. D. M. Smith's co-authors include Charles B. Heiser, R. A. Sacher, Jacqueline Smith, George Garratty, Joy Fridey, Bruce Newman, Edward L. Murphy, Catharie C. Nass, John W. Engstrom and Helen Turner and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and British Journal of Cancer.

In The Last Decade

D. M. Smith

11 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. M. Smith United States 6 125 75 74 74 65 11 290
Antara Datta United States 6 92 0.7× 248 3.3× 57 0.8× 57 0.8× 38 0.6× 8 330
Naofumi Hikita Japan 11 136 1.1× 71 0.9× 41 0.6× 43 0.6× 8 0.1× 14 380
Morgan Thénoz France 8 86 0.7× 173 2.3× 51 0.7× 52 0.7× 22 0.3× 10 265
Zhansheng Zhu China 11 78 0.6× 234 3.1× 3 0.0× 23 0.3× 37 0.6× 25 373
Wei Zhong Leong Singapore 8 81 0.6× 243 3.2× 21 0.3× 14 0.2× 48 0.7× 13 366
Steven Shoei‐Lung Li Taiwan 10 16 0.1× 249 3.3× 12 0.2× 15 0.2× 21 0.3× 15 409
Marilyn Marron United States 6 226 1.8× 90 1.2× 12 0.2× 17 0.2× 121 1.9× 11 328
Vinayak Doraiswamy United States 7 49 0.4× 190 2.5× 3 0.0× 72 1.0× 25 0.4× 8 404
Junya Makiyama Japan 9 120 1.0× 39 0.5× 59 0.8× 51 0.7× 19 0.3× 19 192

Countries citing papers authored by D. M. Smith

Since Specialization
Citations

This map shows the geographic impact of D. M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. M. Smith more than expected).

Fields of papers citing papers by D. M. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. M. Smith. The network helps show where D. M. Smith may publish in the future.

Co-authorship network of co-authors of D. M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of D. M. Smith. A scholar is included among the top collaborators of D. M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. M. Smith. D. M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cook, Natalie, Bristi Basu, D. M. Smith, et al.. (2018). A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer. 118(6). 793–801. 96 indexed citations
2.
Heskamp, Sandra, Linda Heijmen, Danny Gerrits, et al.. (2016). Response Monitoring with [18F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases. Molecular Imaging and Biology. 19(4). 540–549. 6 indexed citations
3.
Heinzmann, Kathrin, Davina J. Honess, David Y. Lewis, et al.. (2016). The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models. EJNMMI Research. 6(1). 63–63. 10 indexed citations
4.
Smith, D. M., R. Brunet, Xavier Adhoute, et al.. (2006). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in second and third-line treatment of metastatic colorectal cancer (mCRC): Safety and efficacy analysis. Journal of Clinical Oncology. 24(18_suppl). 3558–3558. 3 indexed citations
5.
Potkul, Ronald K., et al.. (2004). Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Gynecologic Oncology. 96(3). 701–704. 21 indexed citations
6.
Engstrom, John W., Joy Fridey, R. A. Sacher, et al.. (2003). Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. 61(11). 1588–1594. 124 indexed citations
8.
Smith, D. M., et al.. (1974). Maturation of the Emetic Apparatus in the Dog. American Journal of Veterinary Research. 35(10). 1281–1283. 5 indexed citations
9.
Williams, Richard D. & D. M. Smith. (1970). Preparation of Blowfly Salivary-Gland Chromosomes. The American Biology Teacher. 32(8). 491–492. 1 indexed citations
10.
Larson, C. L., Robert E. Baker, Mary Baker, & D. M. Smith. (1969). Delayed Hypersensitivity Induced in Guinea Pigs with Tuberculoprotein from M. bovis (BCG). Experimental Biology and Medicine. 131(1). 100–104. 1 indexed citations
11.
Heiser, Charles B. & D. M. Smith. (1954). New chromosome numbers in Helianthus and related genera (Compositae). Proceedings of the Indiana Academy of Science. 64. 250–253. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026